• Home
  • Stock
  • Concord Biotech Fundamental Analysis
  • Concord Biotech Fundamental Analysis

Concord Biotech fundamental analysis

CONCORDBIO

HealthcareLarge

1408.5

3.50 (0.25%)
Last updated on 4 Dec, 2025 | 14:36 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Concord Biotech Fundamentals

P/E Ratio

45.4

P/B Ratio

8.05

Div. Yield

0.76

Sector P/E

36.44

Sector P/B

0.91

Sec. Div. Yield

0.56

  • Concord Biotech Fundamentals is currently trading with a P/E Ratio of 45.4, compared to the sector average of 36.44. Its P/B Ratio stands at 8.05, while the sector’s is 0.91. In terms of returns, the stock offers a Dividend Yield of 0.76%, which is than the sector’s 0.56%.

Concord Biotech Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Concord Biotech reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.